Sort
48,018 grants matching “immunotherapy”
Tumor Antigens for Individual Signatures and Therapy
$357,758Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2012 · CA
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
$357,750Yiping Yang · Duke University · R01 · FY2016 · CA
ACCESSING THE MHC CLASS I ANTIGEN PROCESSING PATHWAY
$357,750Thomas Jefferson University · R01 · FY2001 · AI
ACCESSING THE MHC CLASS I ANTIGEN PROCESSING PATHWAY
$357,750Thomas Jefferson University · R01 · FY2005 · AI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
$357,750Yiping Yang · Duke University · R01 · FY2017 · CA
Computational approaches for identifying epigenomic contexts of somatic mutations
$357,750Subhajyoti De · Rutgers Biomedical And Health Sciences · R01 · FY2023 · GM
Computational approaches for identifying epigenomic contexts of somatic mutations
$357,750Subhajyoti De · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · GM
Computational approaches for identifying epigenomic contexts of somatic mutations
$357,750Subhajyoti De · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · GM
ACCESSING THE MHC CLASS I ANTIGEN PROCESSING PATHWAY
$357,750Thomas Jefferson University · R01 · FY2004 · AI
Genetic Approaches to Enhance the Anti-Tumor Functions of T Lymphocytes
$357,733Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
Genetically Engineered Viruses for Prostate Cancer Ther
$357,726Massachusetts General Hospital · R01 · FY2004 · CA
TARGETING DISTINCT IMMUNOSUPPRESSIVE MECHANISMS TO ACHIEVE SYNERGY FOR PROSTATE CANCER IMMUNOTHERAPY
$357,721The University Of Texas Southwestern Medical Center · · FY2014 · Department of Defense
IN VITRO/IN VIVO ACTIVATED DENDRITIC CELLS FOR MELANOMA
$357,719University Of Southern California · R01 · FY2003 · CA
Generation, Diversity and Homeostasis of T Cells Subsets throughout the Body
$357,708Donna L Farber · Columbia University Health Sciences · P01 · FY2016 · AI
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
$357,673Steven Mark Albelda · University Of Pennsylvania · R01 · FY2013 · CA
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
$357,673Steven Mark Albelda · University Of Pennsylvania · R01 · FY2017 · CA
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
$357,673Steven Mark Albelda · University Of Pennsylvania · R01 · FY2016 · CA
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
$357,673Steven Mark Albelda · University Of Pennsylvania · R01 · FY2015 · CA
HIFU and Immunotherapy Treatment of Metastatic Prostate Cancer
$357,671Narendra T Sanghvi · Focus Surgery, Inc. · R44 · FY2009 · CA
Development of promoters of dendritic spine formation
$357,631Jerry Yang · University Of California, San Diego · R01 · FY2018 · AG
A Fully Synthetic Carbohydrate-based Cancer Vaccine
$357,619Geert-Jan Boons · University Of Georgia · R01 · FY2015 · CA
A Fully Synthetic Carbohydrate-based Cancer Vaccine
$357,619Geert-Jan Boons · University Of Georgia · R01 · FY2012 · CA
A Fully Synthetic Carbohydrate-based Cancer Vaccine
$357,618Geert-Jan Boons · University Of Georgia · R01 · FY2011 · CA
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$357,535Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2018 · CA
Impact of Endogenous DOPA Signaling on Melanocyte Homeostasis and Melanoma Susceptibility
$357,500Todd W Ridky · University Of Pennsylvania · R56 · FY2021 · AR